2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 1 studies
Studies (2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene) | Trials (2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene) | Recent Studies (post-2010) (2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene) | Studies (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Trials (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Recent Studies (post-2010) (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) |
---|---|---|---|---|---|
10 | 0 | 0 | 449 | 1 | 24 |
Protein | Taxonomy | 2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene (IC50) | 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (IC50) |
---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 4.55 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 4.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 4.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 4.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
1 other study(ies) available for 2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |